Dr. Meza is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
429 Heymann Blvd
Lafayette, LA 70503Phone+1 337-234-4535
Education & Training
- Ochsner Clinic FoundationResidency, Internal Medicine, 1974 - 1976
- Louisiana State University School of MedicineResidency, Internal Medicine, 1971 - 1974
- Universidad Nacional de Asuncion Faculty of MedicineClass of 1966
Certifications & Licensure
- LA State Medical License 1976 - 2019
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 69 citationsCapecitabine Plus Paclitaxel As Front-Line Combination Therapy for Metastatic Breast Cancer: A Multicenter Phase II StudyWilliam J. Gradishar, Luis A. Meza, Bipinkumar Amin, Dvorit Samid, Todd Hill
Journal of Clinical Oncology. 2004-06-15 - 13 citationsFilgrastim-mediated neutrophil recovery in patients with breast cancer treated with docetaxel and doxorubicin.Luis A. Meza, Michael D. Green, James Hackett, Theresa A. Neumann, Frankie A. Holmes
Pharmacotherapy. 2003-11-01
Press Mentions
- Osel Announces Positive Results from Phase 1b Trial of Live Biotherapeutic Product CBM588 in Combination with Checkpoint Inhibitor (CPI) Therapy in Metastatic Renal Cell CarcinomaJune 7th, 2021
Professional Memberships
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: